No US office = NO trial
AU office = NO MENDS trial.
I think 24 candidates was too many. Maybe you guys should stick with below 10?
When the FDA see you can't run a 24 candidate trial in your own back yard?
Under 8's.
Your management is displaying very clearly how out of their depth they are and you just can't see it. Love is blind.
How much of the burn was stopped by walking away from the MEND trial that was spouted as being over half way through a matter of weeks before dropping it like it was stolen?
The more Ross saves, the better off the company is?
Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-183
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |